Bioanalytical Systems,Inc.(NASDAQ:BASI)today announced financial results for the fourth quarter and fiscal 2013,highlighted by net income of$252,000,or$0.03 per diluted share,for the fourth quarter and$773,000,or$0.09 per diluted share,for ...
Tags: Bioanalytical Systems, financial results for the fourth quarter
Bioanalytical Systems (BASi) has entered into a collaboration with Pinnacle Technology for in proof-of-concept studies combining BASi's Culex NxT automated blood sampling system with Pinnacle's glucose sensor to create a new option for ...